Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/1/2001
 
First Published:
7/1/2001
1.
Phase II Study of Acitretin in Patients With Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas, or other Retinoid-Responsive Diseases or Malignancies (Summary Last Modified 09/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Any age
NCI-77-AR-0172
NCT00020956
Last Modified:
12/6/2007
 
First Published:
11/1/1998
2.
Randomized Study of Acitretin in Patients with Multiple Prior Skin Cancers Who Received Solid Organ Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Prevention
Completed
18 and over
NCI
NCCTG-969251
NCI-P98-0137, NCT00003611
First Published:
3/21/2008
3.
Randomized Study of Acitretin in Patients at High Risk for Basal Cell Carcinoma or Squamous Cell Carcinoma of the Skin
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Prevention
Closed
18 and over
NCI
MAYO-MC02C8
MC02C8, NCT00644384
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute